Linear accelerator-based stereotactic radiosurgery in recurrent glioblastoma: A single center experience;Stereotaksična radiohirurgija uz pomoć linearnog akceleratora kod rekurentnog glioblastoma - iskustvo jednog centra

Vojnosanitetski Pregled

Volumn 68, Issue 11, 2011, Pages 961-966

  Sirin, Sait ^a   Oysul, Kaan ^a   Surenkok, Serdar ^a   Sager, Omer ^a   Dincoglan, Ferrat ^a   Dirican, Bahar ^a   Beyzadeoglu, Murat ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Glioblastoma; Palliative care; Particle accelerators; Radiosurgery; Recurrence

Indexed keywords

DEXAMETHASONE; HISTAMINE H2 RECEPTOR AGONIST; STEROID;

ADULT; AGED; ARTICLE; BRAIN RADIOGRAPHY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HEADACHE; HUMAN; IMAGE ENHANCEMENT; IMAGE QUALITY; KARNOFSKY PERFORMANCE STATUS; LINEAR ACCELERATOR; MALE; OVERALL SURVIVAL; POSTOPERATIVE NAUSEA AND VOMITING; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; SAFETY; STEREOTACTIC RADIOSURGERY; SURVIVAL TIME; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PALLIATIVE CARE; RADIOSURGERY; YOUNG ADULT;

EID: 80955125542     PISSN: 00428450     EISSN: None     Source Type: Journal    
DOI: 10.2298/VSP1111961S     Document Type: Article

References (36)

1. Stupp R, Mason WP, Bent MJ, Van den Weller M, Fischer B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005; 352(10): 987-96.
2. Stupp R, Hegi ME, Mason WP, Bent MJ, Van den Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 2009;10(5):459-66.
3. Gorlia T, Bent MJ, van den Hegi ME, Mirimanoff RO, Weller M, Cairncross JG, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. Lancet Oncol 2008; 9(1):29-38.
4. Mirimanoff RO, Gorlia T, Mason W, Bent MJ, Van den Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol 2006; 24(16): 2563-9.
5. Curran WJ Jr, Scott CB, Horton J, Nelson JS, Weinstein AS, Fischbach AJ, et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85(9): 704-10.
6. Nieder C, Grosu AL, Molls M. A comparison of treatment results for recurrent malignant gliomas. Cancer Treat Rev 2000; 26(6): 397-409.
7. Nieder C, Wiedenmann N, Andratschke N, Molls M. Current status of angiogenesis inhibitors combined with radiation therapy. Cancer Treat Rev 2006; 32(5): 348-64.
8. Harsh GR, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB. Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 1987; 21(5): 615-21.
9. Dirks P, Bernstein M, Muller PJ, Tucker WS. The value of reoperation for recurrent glioblastoma. Can J Surg 1993; 36(3): 271-5.
10. Chua SL, Rosenthal MA, Wong SS, Ashley DM, Woods AM, Dowling A, et al. Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme. Neuro Oncol 2004; 6(1): 38-43.
11. Chamberlain MC, Tsao-Wei DD. Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme. Cancer 2004; 100(6): 1213-20.
12. Brandes AA, Pasetto LM, Monfardini S. New drugs in recurrent high grade gliomas. Anticancer Res 2000; 20(3B): 1913-20.
13. Mayer R, Sminia P. Reirradiation tolerance of the human brain. Int J Radiat Oncol Biol Phys 2008; 70(5): 1350-60.
14. Chamberlain MC, Barba D, Kormanik P, Berson AM, Saunders WM, Shea MC. Concurrent cisplatin therapy and iodine 125 brachytherapy for recurrent malignant brain tumors. Arch Neurol 1995; 52(2): 162-7.
15. Scharfen CO, Sneed PK, Wara WM, Larson DA, Phillips TL, Prados MD, et al. High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992; 24(4): 583-91.
16. Mahajan A, McCutcheon IE, Suki D, Chang EL, Hassenbusch SJ, Weinberg JS, et al. Case-control study of stereotactic radiosurgery for recurrent glioblastoma multiforme. J Neurosurg 2005; 103(2): 210-7.
17. Shrieve DC, Alexander E III, Wen PY, Fine HA, Kooy HM, Black PM, et al. Comparison of stereotactic radiosurgery and brachytherapy in the treatment of recurrent glioblastoma multiforme. Neurosurgery 1995; 36(2): 275-84.
18. Maranzano E, Anselmo P, Casale M, Trippa F, Carletti S, Principi M, et al. Treatment of recurrent glioblastoma with stereotactic radiotherapy: long-term results of a mono-institutional trial. Tumori 2011; 97(1): 56-61.
19. Hsieh PC, Chandler JP, Bhangoo S, Panagiotopoulos K, Kalapurakal JA, Marymont MH, et al. Adjuvant gamma knife stereotactic radiosurgery at the time of tumor progression potentially improves survival for patients with glioblastoma multiforme. Neurosurgery 2005; 57(4): 684-92.
20. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D. Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 2005; 23(34): 8863-9.
21. Kong DS, Lee JL, Park K, Kim JH, Lim DH, Nam DH. Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas. Cancer 2008; 112(9): 2046-51.
22. Fogh SE, Andrews DW, Glass J, Curran W, Glass C, Champ C, et al. Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas. J Clin Oncol 2010; 28(18): 3048-53.
23. Patel M, Siddiqui F, Jin JY, Mikkelsen T, Rosenblum M, Movsas B, et al. Salvage reirradiation for recurrent glioblastoma with radiosurgery: radiographic response and improved survival. J Neurooncol 2009; 92(2): 185-9.
24. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990; 8(7): 1277-80.
25. Hou LC, Veeravagu A, Hsu AR, Tse VC. Recurrent glioblastoma multiforme: a review of natural history and management options. Neurosurg Focus 2006; 20(4): E5.
26. Wallner KE, Galicich JH, Krol G, Arbit E, Malkin MG. Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1989; 16(6): 1405-9.
27. Sneed PK, Gutin PH, Larson DA, Malec MK, Phillips TL, Prados MD, et al. Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 1994; 29(4): 719-27.
28. Leibel SA, Scott CB, Loeffler JS. Contemporary approaches to the treatment of malignant gliomas with radiation therapy. Semin Oncol 1994; 21(2): 198-219.
29. Combs SE, Gutwein S, Thilmann Ch, Huber P, Debus J, Schulz-Ertner D. Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol 2005; 74(2): 167-171.
30. Brem H, Piantadosi S, Burger PC, Walker M, Selker R, Vick NA, et al. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group. Lancet 1995; 345(8956): 1008-12.
31. Cardinale R, Won M, Choucair A, Gillin M, Chakravarti A, Schultz C, et al. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Int J Radiat Oncol Biol Phys 2006; 65(5): 1422-8.
32. Souhami L, Seiferheld W, Brachman D, Podgorsak EB, Werner-Wasik M, Lustig R, et al. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol. Int J Radiat Oncol Biol Phys 2004; 60(3): 853-60.
33. Hau P, Baumgart U, Pfeifer K, Bock A, Jauch T, Dietrich J, et al. Salvage therapy in patients with glioblastoma: is there any benefit? Cancer 2003;98(12): 2678-86.
34. Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB. Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 1999; 45(5): 1133-41.
35. Hall WA, Djalilian HR, Sperduto PW, Cho KH, Gerbi BJ, Gibbons JP, et al. Stereotactic radiosurgery for recurrent malignant gliomas. J Clin Oncol 1995; 13(7): 1642-8.
36. Combs SE, Widmer V, Thilmann C, Hof H, Debus J, Schulz-Ertner D. Stereotactic radiosurgery (SRS): treatment option for recurrent glioblastoma multiforme (GBM). Cancer 2005; 104(10): 2168-73.